Theoretical justification of the choice of API in the composition of extemporal gel for treatment of wounds and bedsores

Authors

DOI:

https://doi.org/10.24959/ubphj.20.280

Keywords:

pharmacotherapy, chronic wounds, bedsores, decamethoxine, hyaluronic acid, extemporaneous gel

Abstract

Topicality. Treatment of chronic wounds and bedsores remains an urgent problem today, which requires the development of effective and safe drugs. Regardless of the cause, the pathogenesis of chronic wounds and bedsores is based on violations of trophic and protective properties of the skin, which develop due to tissue hypoxia.

Aim. The aim of this work is theoretical research to substantiate the choice of active pharmaceutical ingredients (API) in the composition of extemporaneous gel for the treatment of chronic wounds and bedsores.

Materials and methods. Methods of systematic and comparative analysis and bibliosemantic method of studying the modern view on the treatment of chronic wounds and the use of API for their treatment were used to search for information.

Results and discussion. The article shows the relevance of the use of active pharmaceutical ingredients (decamethoxine and hyaluronic acid). Analysis of the literature showed that decamethoxine has a pronounced antibacterial, fungicidal and virocidal action, as well as has anti-inflammatory activity; hyaluronic acid - stimulates repair processes and accelerates epithelialization of wounds.

Conclusions. The choice of API (decamethoxine and hyaluronic acid) in the composition of extemporaneous gel for the treatment of wounds and bedsores is theoretically substantiated.

Author Biographies

G. Melnyk, National University of Pharmacy of the Ministry of Health of Ukraine

postgraduate student, of the Department of Drug’s Technology

T. Yarnykh, National University of Pharmacy of the Ministry of Health of Ukraine

Doctor of Pharmacy, Professor, Head of the Department of Drug’s Technology

M. Buryak, National University of Pharmacy of the Ministry of Health of Ukraine

PhD in Pharmacy, Associate professor of the Department of Drug’s Technology

References

Bekara, F., Vitse, J., Fluieraru. S., Masson, R., Runz, A., Georgescu, V. et al. (2018). New techniques for wound management: A systematic review of their role in the management of chronic wounds. Arch Plast Surg., 45 (2), 102-110. doi: 10.5999/aps.2016.02019.

Ilenghoven, D. A. (2017). Review of Wound Dressing Practices. Clinical Dermatology Open Access Journal, 2 (6), 1-12. doi: 10.23880/CDOAJ-16000133.

Cwaliński, J., Paszkowski, J., Banasiewicz, T. (2018). New perspectives in the treatment of hard-to-heal wound. Wound Therapy Journal, 5 (4), 10-12. doi: 10.18487/npwtj.v5i4.45.

Frykberg, R. G., Jaminelli, B. (2015). Challenges in the Treatment of Chronic Wounds. Advances in Wound Care, 4 (9), 560-582. doi: 10.1089/wound.2015.0635.

Colenci, R. L., Abbade, P. F. (2018). Fundamental aspects of the local approach to cutaneous ulcers. Analytic Bras Dermatology, 93 (6), 859-70. doi: 10.1590/abd1806-4841.20187812.

Lim, K., Free, B., Sinha, S. (2015). Modified TIME-H: a simplified scoring system for chronic wound management. Journal Wound Care, 24 (9), 415-419. doi: 10.12968/jowc.2015.24.9.415.

Laurel, Mt. (2015). Methods of Wound Debridement: Best Practice for Clinicians. Wound, Ostomy and Continence Nurses Society™. Available from: https://cdn.ymaws.com/www.wocn.org/resource/resmgr/Publications/Methods_of_Wound_Debridement.pdf?hhSearchTerms=».

El-Sabbagh, A. H. (2017). Negative pressure wound therapy: An update. Chin J Traumatol, 20 (2), 103-107. doi: 10.1016/j.cjtee.2016.09.004.

Johani, K., Malone, M., Jensen, S. O. (2018). Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo. Journal of Antimicrobial Chemotherapy, 73 (2), 494-502. doi: 10.1093/jac/dkx391.

Aya, K. L., Stern, R. (2015). Hyaluronan in wound healing: rediscovering a major player. Wound Repair Regen., 5, 579–93. doi: 10.1111/wrr.12214.

Voigt, J., Driver, V. R. (2012). Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: A systematic review and meta-analysis of randomized controlled trials. Wound Repair and Regeneration, 20 (3), 317-331. doi: 10.1111/j.1524-475X.2012.00777.x.

Snetkov, P., Morozkina, S., Uspenskaya, M., Olekhnovich, R. (2019). Hyaluronan-Based Nanofibers: Fabrication, Characterization and Application. Polymers (Basel), 11 (12), 2032-2036. doi: 10.3390/polym11122036.

Longinotti, C. (2014). The use of hyaluronic acid based dressings to treat burns: A review. Burn Trauma, 2, 162–168. doi: 10.4103/2321-3868.142398.

Manna, B., Morrison, C. A. (2020). Wound Debridement. Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK507882/.

Downloads

Published

2020-09-18

Issue

No. 3(64) (2020)

Section

Biopharmaceutical research

License

Copyright (c) 2020 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).